poor statin adherence reduced mortality by 35% and that discontinuation increased mortality risk by 90%
Currently in Phase 3 clinical trials and not yet FDA-approved, retatrutide is studied for its ability to amplify energy expenditure beyond what single or dual agonists achieve
neuropeptide DSIP (research-grade) Class: Peptide (research use) Form: Lyophilised powder Appearance: White to off-white solid Note: Counter-ion/hydration state may vary
Additionally, GHK-Cu: Promotes wound healing and reduces post-acne scarring Modulates matrix metalloproteinases (MMPs), preventing excessive tissue breakdown Supports balanced skin remodelling This makes it particularly effective for: Active acne Acne-prone skin undergoing treatments Post-inflammatory hyperpigmentation and scarring By integrating GHK-Cu into acne protocols, we not only treat breakouts but actively repair and strengthen the skinreducing recurrence and improving long-term skin health
Semax: from ACTH4-10 to the neurotrophic tool Origin and structure Semax is a synthetic heptapeptide developed in the 1980s at the Institute of Molecular Biology in Moscow
Potential therapies Although some researchers have attempted to establish a treatment for ME/CFS and no reproducible results have been found (60), some treatments seem promising in ME/CFS ( Figure 13 )
